A Review of the Mechanism of Action of Cyclosporine A: The Role of Cyclosporine A in Dry Eye Disease and Recent Formulation Developments by Periman LM, Mah FS, Karpecki PM

Get full text

Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry Eye by White DE, Zhao Y, Ogundele A, Fulcher N, Acs A, Moore-Schiltz L, Karpecki PM

Get full text

Presbyopia – A Review of Current Treatment Options and Emerging Therapies by Katz JA, Karpecki PM, Dorca A, Chiva-Razavi S, Floyd H, Barnes E, Wuttke M, Donnenfeld E

Get full text

Considerations for the Identification and Management of Geographic Atrophy: Recommendations from an Expert Panel by Regillo CD, Nijm LM, Shechtman DL, Kaiser PK, Karpecki PM, Ryan EH, Ip MS, Yeu E, Kim T, Rafieetary MR, Donnenfeld ED

Get full text

Delphi Panel Consensus Regarding Current Clinical Practice Management Options for Demodex blepharitis by Farid M, Ayres BD, Donnenfeld E, Gaddie IB, Gupta PK, Holland E, Lindstrom R, Pflugfelder SC, Karpecki PM, Nichols KK, Starr CE, Yeu E

Get full text

Phentolamine Mesylate Ophthalmic Solution Provides Lasting Pupil Modulation and Improves Near Visual Acuity in Presbyopic Glaucoma Patients in a Randomized Phase 2b Clinical Trial by Pepose JS, Hartman PJ, DuBiner HB, Abrams MA, Smyth-Medina RJ, Moroi SE, Meyer AR, Sooch MP, Jaber RM, Charizanis K, Klapman SA, Amin AT, Yousif JE, Lazar ES, Karpecki PM, Slonim CB, McDonald MB

Get full text